Third, a growing body of evidence indicates the chemokine/chemokine receptor axes affect Aβ and tau pathologies [32, 34–36], glymphatic function, cognition, or neuroinflammation [21, 36] in AD mouse models. This evidence concerns the gene MAPT and Alzheimer disease.